• Home
  • E-Paper
  • Archive
  • Contact us
  • Daily Pakistan
Thursday, July 7, 2022
  • Login
No Result
View All Result
  • Home
  • Top Stories
  • National
  • City
  • World
  • Sports
  • Technology
  • Editorial
  • Opinion
  • E-Paper
  • Home
  • Top Stories
  • National
  • City
  • World
  • Sports
  • Technology
  • Editorial
  • Opinion
  • E-Paper
No Result
View All Result
Daily The Patriot
No Result
View All Result
Home Globe

WHO approves AstraZeneca/Oxford COVID-19 vaccine for emergency use

by News Desk
June 12, 2021
in Globe
0
WHO approves AstraZeneca/Oxford COVID-19 vaccine for emergency use
0
SHARES
10
VIEWS
Share on FacebookShare on Twitter

The World Health Organization (WHO) on Monday listed AstraZeneca and Oxford University’s COVID-19 vaccine for emergency use, widening access to the relatively inexpensive shot in the developing world.

“We now have all the pieces in place for the rapid distribution of vaccines. But we still need to scale up production,” Tedros Adhanom Ghebreyesus, WHO Director-General, told a news briefing.

“We continue to call for COVID19 vaccine developers to submit their dossiers to WHO for review at the same time as they submit them to regulators in high-income countries,” he said.

A WHO statement said it had approved the vaccine as produced by AstraZeneca-SKBio (Republic of Korea) and the Serum Institute of India.

The listing by the UN health agency comes days after a WHO panel provided interim recommendations on the vaccine, saying two doses with an interval of around 8 to 12 weeks should be given to all adults, and can be used in countries with the South African variant of the coronavirus as well.

The WHO’s review found that the Astrazeneca vaccine met the “must-have” criteria for safety, and its efficacy benefits outweighed its risks.

The AstraZeneca/Oxford shot has been hailed because it is cheaper and easier to distribute than some rivals, including Pfizer/BioNTech’s, which was listed for emergency use by the WHO late in December.

Nearly 109 million people have been reported to be infected by the novel coronavirus globally and more than 2.5 million have died, according to a Reuters tally.

Infections have been reported in more than 210 countries and territories since the first cases were identified in China in December 2019.

Doses of AstraZeneca’s vaccine make up the lion’s share of doses in the COVAX coronavirus vaccine sharing scheme, with more than 330 million doses of the shot due to begin being rolled out to poorer countries from the end of February.

The WHO established its emergency use listing (EUL) process to help poorer countries without their own regulatory resources quickly approve medicines new diseases like COVID-19, which otherwise could lead to delays.

The COVAX Facility, which is co-led by GAVI, the World Health Organization, the Coalition for Epidemic Preparedness Innovations and the U.N. Children’s Fund, has said doses would cover an average of 3.3% of total populations of 145 participating countries.

Tags: AstraZenecaCOVID-19dailythepatriotvaccine
News Desk

News Desk

Next Post
Scientists discover life under 890 meters of ice in Antarctica

Scientists discover life under 890 meters of ice in Antarctica

Latest News

Fostering affiliation
Editorial

Unreliable epoch

by Daily Patriot
July 7, 2022
0

Imran Khan, a former prime minister, is not pleased. In a speech yesterday that was apparently addressed to "the people,"...

Read more
PM Shehbaz launches Green and Blue metro bus services

PM Shehbaz launches Green and Blue metro bus services

July 7, 2022
Amazon partners with Grubhub to provide fee-free food to Prime subscribers

Amazon partners with Grubhub to provide fee-free food to Prime subscribers

July 7, 2022
TikTok restored in Pakistan

US senators want TikTok to be given more scrutiny

July 7, 2022
PM resolves to transform Pakistan into an economic power

Launch of the Green and Blue Metro Bus Service by PM Shehbaz

July 7, 2022
  • Home
  • Top Stories
  • National
  • City
  • World
  • Sports
  • Technology
  • Editorial
  • Opinion
  • E-Paper

© 2020 DAILY PATRIOT - Powered By SmartX DigitalSMARTX DIGITAL.

No Result
View All Result
  • Home
  • Top Stories
  • National
  • City
  • World
  • Sports
  • Technology
  • Editorial
  • Opinion
  • E-Paper

© 2020 DAILY PATRIOT - Powered By SmartX DigitalSMARTX DIGITAL.

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In